13333-87-4 Usage
Uses
Used in Pharmaceutical Research and Development:
AKOS BC-3144 is used as a research compound for the development of new pharmaceuticals. Its chiral nature allows it to be used in the synthesis of chiral pharmaceuticals, which can have different biological activities and properties.
Used in Drug Production:
AKOS BC-3144 is used as an intermediate in the production of various drugs and pharmaceuticals. Its versatility and solubility in water make it a valuable component in the formulation of medications.
Used in Chiral Synthesis:
AKOS BC-3144 is used as a chiral building block in the synthesis of enantiomerically pure compounds. Its unique stereochemistry allows for the creation of chiral drugs with specific biological activities and reduced side effects.
Used in Analytical Chemistry:
AKOS BC-3144 can be used as a reference compound in analytical chemistry for the determination of enantiomeric purity and the development of chiral separation techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 13333-87-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,3 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 13333-87:
(7*1)+(6*3)+(5*3)+(4*3)+(3*3)+(2*8)+(1*7)=84
84 % 10 = 4
So 13333-87-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H8Cl2O3/c1-5-2-6(10)3-7(11)9(5)14-4-8(12)13/h2-3H,4H2,1H3,(H,12,13)
13333-87-4Relevant academic research and scientific papers
Preparation method of chlorophenoxycarboxylic acid substance
-
Paragraph 0045-0048, (2019/01/08)
The invention provides a preparation method of a chlorophenoxycarboxylic acid substance, wherein the preparation method includes the steps: S1) carrying out mixed reaction of phenoxy fatty alcohol represented by the formula (I), an oxidant, an oxidation catalyst and an alkaline substance, and filtering to obtain a reaction liquid; and S2) carrying out mixed reaction of the reaction liquid, a catalyst A, a catalyst B and a chlorinating agent to obtain the chlorophenoxycarboxylic acid substance represented by the formula (II). Compared with the prior art, phenoxy fatty alcohol is firstly directly oxidized in the oxidation catalyst and the alkaline environment to obtain phenoxy fatty acid salt, and then the phenoxy fatty acid salt is subjected to catalytic chlorination to obtain the chlorophenoxycarboxylic acid substance. The preparation method has the advantages of no need of cumbersome concentration device, simple process, no need of high temperature, low energy consumption, high selectivity, low consumption of raw materials and low content of waste water and waste salt.
